Understanding Medical Coding for Long-Term Drug Therapy in ICD-10
- Importance of accurate medical coding in healthcare.
- Focus on long-term drug therapy and its impact on coding.
Coding Long-Term Drug Therapy
- Definition of long-term drug therapy in medical context.
- Importance of documenting drug therapy duration for coding accuracy.
- Examples of conditions requiring long-term drug therapy (e.g., chronic diseases, maintenance therapies).
Coding Guidelines for Long-Term Drug Use
- Specific guidelines for coding chronic conditions under ICD-10.
- Linking diagnosis codes to long-term drug therapy codes.
- Coding considerations for primary and secondary diagnoses.
Z79 Long-term (current) drug therapy
Codes from this category indicate a patient’s continuous use of a prescribed drug (including such things as aspirin therapy) for the long-term treatment of a condition or for prophylactic use. It is not for use for patients who have addictions to drugs. This subcategory is not for use of medications for detoxification or maintenance programs to prevent withdrawal symptoms (e.g., methadone maintenance for opiate dependence). Assign the appropriate code for the drug use, abuse, or dependence instead.
Assign a code from Z79 if the patient is receiving a medication for an extended period as a prophylactic measure (such as for the prevention of deep vein thrombosis) or as treatment of a chronic condition (such as arthritis) or a disease requiring a lengthy course of treatment (such as cancer). Do not assign a code from category Z79 for medication being administered for a brief period of time to treat an acute illness or injury (such as a course of antibiotics to treat acute bronchitis).
What is considered long-term use of meds?
Common Long-Term Drug Categories
- Classification of drugs commonly used in long-term therapy (e.g., insulin for diabetes, anticoagulants for cardiovascular diseases).
- Corresponding ICD-10 codes for these drug therapies.
- Compliance with coding regulations and standards (e.g., HIPAA, CMS guidelines).
- Common coding errors related to long-term drug therapy.
- Strategies to avoid errors and ensure accurate coding.
- Impact of coding errors on healthcare reimbursement and patient care.
- Recap of the significance of accurate coding for long-term drug therapy.
- Importance of ongoing education and training for healthcare professionals.
- Future trends in medical coding and its impact on long-term drug therapy.
For many coders, that code is Z79.899, Other long-term (current) drug therapy. It is the catchall code when the patient is or has taken a medication on a long-term basis.
Coding Clinic for ICD-10-CM/PCS recommends using this code to capture the use of injectable diabetic drugs, Flonase, or immunosuppressants.
ICD-10 guidelines:
Diabetes mellitus and the use of insulin, oral hypoglycemics,
and injectable non-insulin drugs
If the documentation in a medical record does not indicate the type of
diabetes but does indicate that the patient uses insulin, code E11-, Type 2
diabetes mellitus, should be assigned. Additional code(s) should be
assigned from category Z79 to identify the long-term (current) use of
insulin, oral hypoglycemic drugs, or injectable non-insulin antidiabetic,
as follows:
If the patient is treated with both oral hypoglycemic drugs and insulin,
both code Z79.4, Long-term (current) use of insulin, and code Z79.84,
Long-term (current) use of oral hypoglycemic drugs, should be assigned.
If the patient is treated with both insulin and an injectable non-insulin
antidiabetic drug, assign codes Z79.4, Long-term (current) use of insulin,
and Z79.85, Long-term (current) use of injectable non-insulin
antidiabetic drugs.
If the patient is treated with both oral hypoglycemic drugs and an
injectable non-insulin antidiabetic drug, assign codes Z79.84, Long-term
(current) use of oral hypoglycemic drugs, and Z79.85, Long-term
(current) use of injectable non-insulin antidiabetic drugs.
Code Z79.4 should not be assigned if insulin is given temporarily to
bring a type 2 patient’s blood sugar under control during an encounter
Z79 Long-term (current) drug therapy
Codes from this category indicate a patient’s continuous use
of a prescribed drug (including such things as aspirin therapy)
for the long-term treatment of a condition or for prophylactic
use. It is not for use for patients who have addictions to drugs.
This subcategory is not for use of medications for
detoxification or maintenance programs to prevent
withdrawal symptoms (e.g., methadone maintenance for
opiate dependence). Assign the appropriate code for the drug
use, abuse, or dependence instead.
Assign a code from Z79 if the patient is receiving a
medication for an extended period as a prophylactic measure
(such as for the prevention of deep vein thrombosis) or as
treatment of a chronic condition (such as arthritis) or a
disease requiring a lengthy course of treatment (such as
cancer). Do not assign a code from category Z79 for
medication being administered for a brief period of time to
treat an acute illness or injury (such as a course of antibiotics
to treat acute bronchitis).
https://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf
ICD-10 Codes for Long-term Therapies | |
Code | Long-term (current) use of |
V – Valid For Claim Submission | |
Z79.01 | anticoagulants |
Z79.02 | antithrombotics/antiplatelets |
Z79.1 | NSAIDs |
Z79.2 | antibiotics |
Z79.3 | hormonal contraceptives |
Z79.4 | insulin |
Z79.51 | inhaled steroids |
Z79.52 | systemic steroids |
Z79.810 | selective estrogen receptor modulators |
Z79.811 | aromatase inhibitors |
Z79.818 | other agents affecting estrogen receptors and estrogen levels |
Z79.82 | aspirin |
Z79.83 | bisphosphonates |
Z79.84 | oral hypoglycemic drugs |
Z79.891 | opiate analgesic |
Z79.899 | other drug therapy |
H – Not Valid for Claim Submission | |
Z79 | drug therapy |
Z79.0 | anticoagulants and antithrombotics/antiplatelets |
Z79.5 | steroids |
Z79.8 | other drug therapy |
Z79.81 | agents affecting estrogen receptors and estrogen levels |
Z79.89 | other drug therapy |
Other long term (current) drug therapy list from ICD-10 Data
Approximate Synonyms
Allergen immunotherapy started
Antihypertensive agent surveillance
Antihypertensive medication surveillance done
High-risk medication monitoring
High-risk medication monitoring indicated
Immunodeficiency due to Long-term therapeutic use of drug
Long-term antidepressant medication therapy
Long-term antipsychotic medication therapy
Long-term antiviral therapy
Long-term anxiolytic medication therapy
Long-term apremilast therapy
Long-term current use of abatacept
Long-term current use of abatacept (orencia)
Long-term current use of acetaminophen (tylenol)
Long-term current use of acitretin (soriatane)
Long-term current use of adalimumab (humira)
Long-term current use of amiodarone
Long-term current use of anakinra (kineret)
Long-term current use of anticonvulsant
Long-term current use of aralen (chloroquine)
Long-term current use of azathioprine
Long-term current use of belimumab (benlysta)
Long-term current use of cannabis
Long-term current use of clozapine (clozaril)
Long-term current use of cyclophosphamide
Long-term current use of cyclosporine
Long-term current use of etanercept
Long-term current use of etanercept (enbrel)
Long-term current use of felbamate (felbatol)
Long-term current use of filgrastim (neupogen)
Long-term current use of golimumab (simponi)
Long-term current use of humira
Long-term current use of hydroxychloroquine (plaquenil)
Long-term current use of infliximab (remicade)
Long-term current use of isotretinoin (accutane)
Long-term current use of leflunomide (arava)
Long-term current use of lenalidomide (revlimid)
Long-term current use of lithium
Long-term current use of medication for add and or adhd
Long-term current use of medication for attention deficit disorder (add) or attention deficit hyperactivity disorder (adhd)
Long-term current use of methotrexate
Long-term current use of mycophenolate
Long-term current use of pharmaceutical gold
Long-term current use of plaquenil
Long-term current use of remicade
Long-term current use of retinoid
Long-term current use of rituximab (rituxan)
Long-term current use of sirolimus (rapamune)
Long-term current use of sulfasalazine (azulfidine)
Long-term current use of tacrolimus
Long-term current use of tocilizumab
Long-term diuretic therapy
Long-term drug therapy
Long-term erythropoiesis-stimulating agent therapy
Long-term growth hormone therapy
Long-term intravenous immune globulin therapy
Long-term mercaptopurine therapy
Long-term methotrexate user
Long-term testosterone cypionate (oil-based intramuscular injection) therapy
Long-term tofacitinib therapy
Long term use certolizumab pegol
Long-term ustekinumab therapy
Long-term current use of acitretin
Long-term current use of anakinra
Long-term current use of antidepressant medication
Long-term current use of antipsychotic medication
Long-term current use of antiviral
Long-term current use of anxiolytic medication
Long-term current use of apremilast
Long-term current use of aralen
Long-term current use of belimumab
Long-term current use of certolizumab pegol
Long-term current use of clozapine
Long-term current use of diuretic
Long-term current use of erythropoiesis-stimulating agent
Long-term current use of felbamate
Long-term current use of filgrastim
Long-term current use of golimumab
Long-term current use of growth hormone
Long-term current use of high-dose acetaminophen
Long-term current use of hydroxychloroquine
Long-term current use of intravenous immune globulin
Long-term current use of isotretinoin
Long-term current use of leflunomide
Long-term current use of lenalidomide
Long-term current use of medicinal gold
Long-term current use of mercaptopurine
Long-term current use of rituximab
Long-term current use of sirolimus
Long-term current use of sulfasalazine
Long-term current use of testosterone cypionate
Long-term current use of tofacitinib
Long-term current use of ustekinumab
Malaria prophylaxis given
Medication surveillance, antihypertensive
Monitoring of long-term therapeutic drug use done
Opioid dependence (moderate use disorder) on agonist therapy, in early remission
Opioid dependence (moderate use disorder) on agonist therapy, in sustained remission
Opioid dependence (severe use disorder) on agonist therapy, in early remission
Opioid dependence (severe use disorder) on agonist therapy, in sustained remission
Opioid dependence, moderate use, on agonist therapy, in early remission
Opioid dependence, moderate use, on agonist therapy, in sustained remission
Opioid dependence, severe use on agonist therapy, in early remission
Opioid dependence, severe use on agonist therapy, in sustained remission
Prophylactic (preventative) anticoagulation therapy
Prophylactic (preventative) immunotherapy
Prophylactic (preventative) malaria therapy
Prophylactic (preventative) medication prescription
Prophylactic anticoagulation given
Prophylactic medication given
Therapeutic drug-induced immunosuppression, long-term use